[Opioid use disorders during long-term opioid treatment : Risk factors and action approaches in patients with chronic nontumor pain from an outpatient medical perspective].

IF 0.8 4区 医学 Q3 ANESTHESIOLOGY
Schmerz Pub Date : 2026-09-14 DOI:10.1007/s00482-026-00971-4
Silke Neusser, Anja Niemann, Nils Frederik Schrader, Nikola Blase, Milena Weitzel, Carina Abels, Christian Speckemeier, Anja Neumann, Cordula Riederer, Joachim Nadstawek, Wolfgang Straßmeir, Jürgen Wasem
{"title":"[Opioid use disorders during long-term opioid treatment : Risk factors and action approaches in patients with chronic nontumor pain from an outpatient medical perspective].","authors":"Silke Neusser, Anja Niemann, Nils Frederik Schrader, Nikola Blase, Milena Weitzel, Carina Abels, Christian Speckemeier, Anja Neumann, Cordula Riederer, Joachim Nadstawek, Wolfgang Straßmeir, Jürgen Wasem","doi":"10.1007/s00482-026-00971-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Long-term opioid use (> 3 months) can be an important element in the treatment of patients with chronic nontumor pain but it is also discussed in association with risks for the development of opioid use disorder. This analysis aims to explore the risk factors for opioid use disorder in long-term opioid treatment, barriers for its identification and starting points for different solutions to overcome these barriers from a medical perspective.</p><p><strong>Methods: </strong>A cross-sectional postal survey was sent in Autumn 2021 to 1854 physicians involved in outpatient treatment in Germany. A random sample of 1300 physicians were drawn from the pool of an address service and all members of the Professional Association of Physicians and Psychological Psychotherapists in Pain and Palliative Medicine in Germany (BVSD, n = 554) were contacted. A reminder was sent out in January 2022.</p><p><strong>Results: </strong>A total of 422 physicians participated in the survey, one third were primary care physicians (33%) and 65% had received additional training \"specialist pain therapy\". On a scale from 1 = full approval to 5 = full rejection, treatment of chronic pain by different physicians was perceived as the most important risk factor for opioid use disorder (mean (MW): 1.33, standard deviation (SD): 0.596). Further important risk factors were treatment specific. Intentional disguise by the patient (MW 1.73/SD 0.888) and opioid prescriptions by different physicians (MW 1.79/SD 0.635) were perceived as major hurdles for the identification of opioid use disorder. Regular prescription controls (MW 1.37/SD 0.648) and periodical patient contact (MW 1.49/SD 0.654) were perceived as the most important approach to reveal opioid use disorders.</p><p><strong>Discussion: </strong>The present study gives a quantification of structural and treatment-specific risk factors in the German context. This could serve as an important foundation for the development of a health policy approach to tackle these hurdles. The results indicate that fostering transparency and communication are important aspects.</p>","PeriodicalId":21572,"journal":{"name":"Schmerz","volume":" ","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2026-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schmerz","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00482-026-00971-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Long-term opioid use (> 3 months) can be an important element in the treatment of patients with chronic nontumor pain but it is also discussed in association with risks for the development of opioid use disorder. This analysis aims to explore the risk factors for opioid use disorder in long-term opioid treatment, barriers for its identification and starting points for different solutions to overcome these barriers from a medical perspective.

Methods: A cross-sectional postal survey was sent in Autumn 2021 to 1854 physicians involved in outpatient treatment in Germany. A random sample of 1300 physicians were drawn from the pool of an address service and all members of the Professional Association of Physicians and Psychological Psychotherapists in Pain and Palliative Medicine in Germany (BVSD, n = 554) were contacted. A reminder was sent out in January 2022.

Results: A total of 422 physicians participated in the survey, one third were primary care physicians (33%) and 65% had received additional training "specialist pain therapy". On a scale from 1 = full approval to 5 = full rejection, treatment of chronic pain by different physicians was perceived as the most important risk factor for opioid use disorder (mean (MW): 1.33, standard deviation (SD): 0.596). Further important risk factors were treatment specific. Intentional disguise by the patient (MW 1.73/SD 0.888) and opioid prescriptions by different physicians (MW 1.79/SD 0.635) were perceived as major hurdles for the identification of opioid use disorder. Regular prescription controls (MW 1.37/SD 0.648) and periodical patient contact (MW 1.49/SD 0.654) were perceived as the most important approach to reveal opioid use disorders.

Discussion: The present study gives a quantification of structural and treatment-specific risk factors in the German context. This could serve as an important foundation for the development of a health policy approach to tackle these hurdles. The results indicate that fostering transparency and communication are important aspects.

[长期阿片类药物治疗期间的阿片类药物使用障碍:从门诊医学角度看慢性非肿瘤疼痛患者的危险因素和行动方法]。
背景:长期阿片类药物使用(> 3个月)可能是治疗慢性非肿瘤疼痛患者的一个重要因素,但它也与阿片类药物使用障碍发展的风险相关。本分析旨在从医学角度探讨阿片类药物长期治疗中阿片类药物使用障碍的危险因素、识别障碍以及克服这些障碍的不同解决方案的起点。方法:于2021年秋季向德国参与门诊治疗的1854名医生发送横断面邮政调查。从地址服务池中随机抽取1300名医生,并联系了德国疼痛和姑息医学医师和心理心理治疗师专业协会(BVSD, n = 554)的所有成员。2022年1月发出了一份提醒。结果:共有422名医生参与调查,其中三分之一是初级保健医生(33%),65%接受过“专科疼痛治疗”的额外培训。从1 =完全批准到5 =完全拒绝,不同医生对慢性疼痛的治疗被认为是阿片类药物使用障碍最重要的危险因素(平均值(MW): 1.33,标准差(SD): 0.596)。更重要的危险因素是治疗特异性的。患者故意伪装(MW 1.73/SD 0.888)和不同医生开具的阿片类药物处方(MW 1.79/SD 0.635)被认为是识别阿片类药物使用障碍的主要障碍。常规处方对照(MW 1.37/SD 0.648)和定期患者接触(MW 1.49/SD 0.654)被认为是揭示阿片类药物使用障碍的最重要方法。讨论:目前的研究给出了德国背景下的结构和治疗特异性风险因素的量化。这可以作为制定解决这些障碍的卫生政策办法的重要基础。结果表明,促进透明度和沟通是重要的方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Schmerz
Schmerz 医学-临床神经学
CiteScore
2.00
自引率
20.00%
发文量
64
审稿时长
6-12 weeks
期刊介绍: Der Schmerz is an internationally recognized journal and addresses all scientists, practitioners and psychologists, dealing with the treatment of pain patients or working in pain research. The aim of the journal is to enhance the treatment of pain patients in the long run. Review articles provide an overview on selected topics and offer the reader a summary of current findings from all fields of pain research, pain management and pain symptom management. Freely submitted original papers allow the presentation of important clinical studies and serve the scientific exchange. Case reports feature interesting cases and aim at optimizing diagnostic and therapeutic strategies. Review articles under the rubric ''Continuing Medical Education'' present verified results of scientific research and their integration into daily practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书